ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 167 filers reported holding ALLAKOS INC in Q1 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,321,675 | -46.9% | 4,987,522 | +2.0% | 28.00% | +18.5% |
| Q2 2023 | $21,311,384 | -2.0% | 4,887,932 | 0.0% | 23.64% | -6.1% |
| Q1 2023 | $21,751,297 | -47.1% | 4,887,932 | 0.0% | 25.16% | -47.6% |
| Q4 2022 | $41,156,388 | +37.6% | 4,887,932 | 0.0% | 48.01% | +38.2% |
| Q3 2022 | $29,914,000 | +95.5% | 4,887,932 | 0.0% | 34.73% | +54.5% |
| Q2 2022 | $15,299,000 | -45.1% | 4,887,932 | 0.0% | 22.48% | -21.4% |
| Q1 2022 | $27,861,000 | -41.8% | 4,887,932 | 0.0% | 28.60% | -16.2% |
| Q4 2021 | $47,853,000 | -90.8% | 4,887,932 | 0.0% | 34.14% | -60.7% |
| Q3 2021 | $517,485,000 | +24.0% | 4,887,932 | 0.0% | 86.88% | +6.5% |
| Q2 2021 | $417,283,000 | -25.6% | 4,887,932 | 0.0% | 81.57% | -5.6% |
| Q1 2021 | $561,037,000 | -30.3% | 4,887,932 | -15.0% | 86.41% | -2.3% |
| Q4 2020 | $805,071,000 | – | 5,750,506 | – | 88.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |